Baillie Gifford Shin Nippon

Japanese Equities

Rated Fund 2015-20. Backs the next generation of companies and entrepreneurs

The stablemate to Baillie Gifford Japan, Baillie Gifford Shin Nippon, clinched a hat trick in 2019, when it was named Money Observer’s Best Japan Trust for the third consecutive year. FundCalibre, the fund ratings and research provider, rates this an ‘Elite’ fund and points to its pedigree as the best-performing Japanese fund, both closed- and open-ended, since Shinzo Abe came to power. It has turned £1,000 into £4,650 during his tenure.

Its main differentiator is that it focuses exclusively on high-growth smaller companies. Shin Nippon means ‘new Japan’ and Praveen Kumar, the trust’s manager since the end of 2015, backs 40 to 80 companies in emerging and disruptive sectors, often run by younger, more progressive management than is typical in Japan. Kumar pays little attention to the benchmark, as demonstrated by an ‘active share’ (percentage difference from the benchmark index) of 94%. Although many of Japan’s corporate giants are well known to foreign investors, its smaller companies receive scant investment research coverage, so this part of the market is where some of the strongest gains can be made.

Smaller companies are typically higher-risk, though, making this trust suitable for those who are very optimistic about the outlook for Japanese equities. One such investor is Skerritts Wealth Management. Investment manager Charlie Lloyd says: “We retain conviction in Japan, despite recent volatility. This trust invests in small and mid-caps, so is very much a play on domestic themes in Japan.”

In spring 2018 Shin Nippon was trading on a premium of 14%, but that has since disappeared, contributing to weaker share price performance over 2019. The shares traded at close to net asset value at the end of the year.

Narrative and rating as of January 2020.

See all Money Observer rated funds
Baillie Gifford Shin Nippon
Baillie Gifford & Co Limited.
Closed Ended Investment Company
Japanese Smaller Companies
0.73 %
Risk Rating
3 Year Sharpe
3 Year Alpha
0 %
MSCI Japan Small Cap GR USD
Fund Size
£ 541.26 million
Discount Premium
Aims to achieve long-term capital growth principally through investment in small Japanese companies which are believed to have above average prospects for growth.
Holding % Inc 4.24 %
Demae-Can Co Ltd 3.16 %
GMO Payment Gateway Inc 2.97 %
MonotaRO Co Ltd 2.53 %
COSMOS Pharmaceutical Corp 2.50 %
Infomart Corp 2.50 %
Kitanotatsujin Corp 2.33 %
Raksul Inc Ordinary Shares 2.29 %
eGuarantee Inc 2.29 %
M3 Inc 2.21 %
Region %
Japan 100.00 %
Sector %
Industrials 28.52 %
Technology 24.87 %
Healthcare 13.88 %
Consumer Cyclical 11.83 %
Consumer Defensive 6.45 %
Financial Services 6.08 %
Baillie Gifford & Co Limited.
EH1 3AN, Edinburgh, United Kingdom
Legal Structure
Closed Ended Investment Company


Praveen Kumar
Joined 11/30/2015

Praveen Kumar joined Baillie Gifford in 2008 and became an investment manager on the Japanese Equities team in 2011. He graduated BEng in Computer Science from Bangalore University in 2001, and has an MBA in Finance from Cambridge University in 2008. He previously worked for FKI Logistex before joining Baillie Gifford in 2008.

Data provided by Morningstar.

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Money Observer and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.